Test Price
2,800 AED✅ Home Collection Available
HOXD13 Gene Brachydactyly Type E1 Genetic Test in UAE | 2800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
Our medical diagnostics centre offers a comprehensive HOXD13 gene analysis using Next-Generation Sequencing (NGS), delivering definitive molecular diagnosis for brachydactyly type E1 with 99.9% diagnostic sensitivity. The test is processed under ISO 9001:2015 accredited protocols and supported by DHA-licensed genetic counselling.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015).
- ✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- ✓ Clinical Guidance: Telephonic post-test genetic counselling for result interpretation and family risk assessment.
- ✓ Insurance Verification: Direct billing confirmation via WhatsApp +971 54 548 8731 prior to booking.
Test Overview & Methodology
The HOXD13 Gene Brachydactyly Type E1 Genetic Test utilises state-of-the-art Next-Generation Sequencing (NGS) to detect pathogenic variants in the HOXD13 gene, the definitive molecular cause of brachydactyly type E1. This test provides unequivocal diagnostic confirmation for dysmorphology assessment, family risk stratification, and informed clinical management.
| Feature | Our Test | Closest Alternative (Traditional Sanger) |
|---|---|---|
| Molecular Precision | Full coding region + exon‑intron boundaries via NGS | Single‑exon screening; may miss deep intronic or copy‑number variants |
| Turnaround Time | 3–4 Weeks (ISO cold‑chain logistics) | 4–6 Weeks |
| Regulatory Compliance | DHA/MOHAP Standards, ISO 9001:2015 | Variable local accreditation |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I emphasise that a positive HOXD13 result provides a precise molecular explanation for digital anomalies, yet it must always be integrated with a complete dysmorphology evaluation and three-generation pedigree analysis. This test delivers a definitive genetic diagnosis, however therapeutic and surgical decisions require a multidisciplinary team including a paediatric orthopaedic surgeon and clinical geneticist to optimise functional and developmental outcomes. Pre-test genetic counselling is mandatory per DHA standards.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
This genetic test assesses germline DNA and does not replace clinical monitoring. Do not discontinue, alter, or adjust any prescribed medication without direct consultation with your treating physician. The test results should be used in conjunction with a complete clinical assessment.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active febrile illness or severe coagulation disorder contraindicating phlebotomy; inability to provide written informed consent (or guardian consent for minors). Pre-test genetic counselling must be completed and a pedigree chart documented per DHA protocol prior to sample collection.
- Immediate Medical Attention Red Flags: If the patient experiences sudden severe joint pain, rapid skeletal asymmetry, or new neurological deficits, seek emergency care — these features are not consistent with isolated brachydactyly and may indicate a broader syndromic presentation requiring urgent evaluation.
Patient FAQ & Clinical Guidance
1. What is the accuracy of the HOXD13 genetic test for diagnosing Brachydactyly Type E1?
This NGS-based test delivers 99.9% diagnostic sensitivity by sequencing the entire coding region and exon-intron boundaries of the HOXD13 gene using DHA-validated methodology. It is the gold standard for molecular confirmation of brachydactyly type E1 and enables precise family risk stratification.
2. What sample type is required and can collection be done at home?
A single peripheral blood draw (3 mL in an EDTA tube) or one drop of blood on an FTA card is sufficient. Our ISO-certified phlebotomy team provides VIP Mobile Phlebotomy and Temperature-Controlled Cold-Chain Home Collection across all UAE emirates, available daily from 8 AM to 11 PM.
3. Will my health insurance cover this genetic test?
Many UAE health insurers reimburse medically necessary HOXD13 testing when pre-authorised. Send your policy details via WhatsApp to +971 54 548 8731 for instant verification and cost transparency before booking your appointment.
4. How long does it take to receive results?
The standard turnaround time is 3 to 4 weeks from sample receipt in the laboratory. This timeline ensures thorough NGS data analysis, variant interpretation, and quality control review in accordance with ISO 9001:2015 protocols.
5. Is genetic counselling provided with the test?
Yes. Telephonic post-test genetic counselling is included to help you understand your results, discuss inheritance patterns, and plan any recommended follow-up for family members. Pre-test counselling is also available and is mandatory per DHA regulatory requirements.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework:
- Data Protection: All patient genetic data is processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical Safety & Consent: Patient safety protocols and informed consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring that all genetic testing is conducted with full patient awareness and legal protection.
- Laboratory Accreditation: Our facility operates under DHA Facility License Number 1143 and maintains ISO 9001:2015 certification for quality management systems.
Clinical & Logistical Metadata
| Test Name | HOXD13 Gene Brachydactyly Type E1 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3 mL EDTA) or FTA Card Blood Spot |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Coding Region & Exon-Intron Boundaries |
| ICD-10-CM Code | Q74.8 |
| LOINC Code | 82349-0 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians